首页|Department of Computer Sciences Reports Findings in Artificial Intelligence (Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications)
Department of Computer Sciences Reports Findings in Artificial Intelligence (Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
Wiley
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News – New research on Artificial Intelligence is the subject of a report. According to news reporting originating from Enugu, Nigeria, by NewsRx correspondents, research stated, “The purpose of this study was to discuss how artificial intelligence (AI) methods have affected the field of drug development. It looks at how AI models and data resources are reshaping the drug development process by offering more affordable and expedient options to conventional approaches.” Our news editors obtained a quote from the research from the Department of Computer Sciences, “The paper opens with an overview of well-known information sources for drug development. The discussion then moves on to molecular representation techniques that make it possible to convert data into representations that computers can understand. The paper also gives a general overview of the algorithms used in the creation of drug discovery models based on AI. In particular, the paper looks at how AI algorithms might be used to forecast drug toxicity, drug bioactivity, and drug physicochemical properties. De novo drug design, binding affinity prediction, and other AI-based models for drug-target interaction were covered in deeper detail. Modern applications of AI in nanomedicine design and pharmacological synergism/antagonism prediction were also covered. The potential advantages of AI in drug development are highlighted as the evaluation comes to a close. It underlines how AI may greatly speed up and improve the efficiency of drug discovery, resulting in the creation of new and better medicines.”
EnuguNigeriaAfricaArtificial IntelligenceDrug DevelopmentDrugs and TherapiesEmerging TechnologiesHealth and MedicineMachine Learning